Nitric oxide reduces basal efflux of catecholamines from perfused dog adrenal glands

Journal of the Autonomic Nervous System

Volumn 61, Issue 3, 1996, Pages 235-242

  Ward, Lawrence E ^a   Hunter, Larry W ^a   E Grabau, Curtis ^a   Tyce, Gertrude M ^a   Rorie, Duane K ^a  

^a DEPARTMENT OF UROLOGY   (United States)

Author keywords

Adrenal gland; Catecholamine efflux; Met enkephalin; Nitric oxide; Peptide; Preproenkephalin

Indexed keywords

3,4 DIHYDROXYPHENYLACETIC ACID; 3,4 DIHYDROXYPHENYLETHYLENE GLYCOL; ADRENALIN; CATECHOLAMINE; DOPAMINE; LINSIDOMINE; METENKEPHALIN; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; NITROPRUSSIDE SODIUM; NORADRENALIN; PREPROENKEPHALIN;

ADRENAL GLAND; ANIMAL TISSUE; ARTICLE; CATECHOLAMINE RELEASE; CONTROLLED STUDY; DOG; NONHUMAN; ORGAN PERFUSION; PRIORITY JOURNAL;

ADRENAL GLANDS; ANIMALS; CATECHOLAMINES; DOGS; ENKEPHALIN, METHIONINE; ENZYME INHIBITORS; FEMALE; MALE; MOLSIDOMINE; NA(+)-K(+)-EXCHANGING ATPASE; NEUROPEPTIDES; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITROPRUSSIDE; OMEGA-N-METHYLARGININE; PERFUSION;

EID: 0030583841     PISSN: 01651838     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-1838(96)00089-6     Document Type: Article

References (42)

1. 2+-independent release of neurotransmitters, J. Neurochem., 58 (1992) 395-405.
2. Afework, M., Ralevic, V. and Burnstock, G., The intra-adrenal distribution of intrinsic and extrinsic nitrergic nerve fibres in the rat, Neurosci. Lett., 190 (1995) 109-112.
3. Bowers, C.W., Superfluous neurotransmitters?, Trends Neurosci., 17 (1994) 315-320.
4. Bredt, D.S. and Snyder, S.H., Isolation of nitric oxide synthetase, a calmodulin-requiring enzyme, Proc. Natl. Acad. Sci. USA, 87 (1990) 682-685.
5. G-nitro L-arginine methyl ester and other alkyl esters of arginine are muscarinic receptor antagonists, Circ. Res., 72 (1993) 387-395.
6. Cameron, L.A. and Hinson, J.P., The role of nitric oxide derived from L-arginine in the control of steroidogenesis, and perfusion medium flow rate in the isolated perfused rat adrenal gland, J. Endocrinol., 139 (1993) 415-423.
7. Chaminade, M., Fontz, A.S. and Rossier, J., Co-release of enkephalins and precursors with catecholamines from the perfused cat adrenal gland in situ, J. Physiol., 353 (1984) 157-169.
8. Chritton, S., Chinnow, S., Grabau, C., Dousa, M., Lucas, D., Roddy, D., Yaksh, T. and Tyce, G.M., Adrenal secretion of DOPA, neuropeptides, catecholamines and their metabolites, J. Neurochem. 57(Suppl) (1991) S61A (abstract).
9. Chritton, S., Dousa, M., Grabau, C., Lucas, D., Roddy, D. and Tyce, G., Basal efflux of catecholamines and peptides from perfused dog adrenals, Trans. Am. Soc. Neurochem., 21 (1990) 331 (abstract).
10. Chritton, S.L., Dousa, M.K., Yaksh, T.L. and Tyce, G.M., Nicotinic- and muscarinic-evoked release of canine adrenal catecholamines and peptides, Am. J. Physiol., 260 (1991) R589-R599.
11. Cohen, R.A. and Weisbrod, R.M., Endothelium inhibits norepinephrine release from adrenergic nerves of rabbit carotid artery, Am. J. Physiol., 254 (1988) H871-H878.
12. Dousa, M.K., Chritton, S.L., Grabau, C., Yaksh, T.L. and Tyce, G.M., Atrial natriuretic peptide effects catecholamine release from ex situ perfused dog adrenals, FASEB J., 3 (1989) 3817 (abstract).
13. Dousa, M.K., Chritton, S.L., Grabau, C., Yaksh, T.L. and Tyce, G.M., μ and κ agonists inhibit carbachol-evoked release of catecholamines and [Met]enkephalin from ex situ perfused dog adrenal, Adv. Biosci., 82 (1991) 335-336.
14. Dousa, M.K., Chritton, S.L., Lucas, D.L., Roddy, D.R., Yaksh, T.L. and Tyce, G.M., Release of catecholamines, [Met]enkephalin, and neuropeptide Y from ex situ perfused adrenals during hypoglycemia, Neuroscience, 14 (1988) 682 (abstract).
15. Gaumann, D.M. and Yaksh, T.L., Effects of hemorrhage and opiate antagonists on adrenal release of neuropeptides in cats, Peptides, 9 (1988) 393-405.
16. Gaumann, D.M., Yaksh, T.L. and Lucas, D.L., Cryptic Met-enkephalin in adrenal and portal vein during splanchnic artery occlusion shock in cats, Neurosci. Lett., 116 (1990) 387-392.
17. Gaumann, D.M., Yaksh, T.L., Tyce, G.M. and Stoddard, S.L., Adrenal vein catecholamines and neuropeptides during splanchnic nerve stimulation in cats, Peptides, 10 (1989) 587-592.
18. Goldstein, D.S. and Eisenhofer, G., Plasma catechols - what do they mean?, New Physiol. Sci., 3 (1988) 138-144.
19. Haass, M., Hock, M., Richardt, G. and Schömig, A., Neuropeptide Y differentiates between exocytotic and nonexocytotic noradrenaline release in guinea-pig heart, Naunyn-Schmiedeberg's Arch. Pharmacol., 340 (1989) 509-515.
20. Hanbauer, I., Govoni, S., Majane, E.A., Yang, H.-Y.T. and Costa, E., In vivo regulation of the release of Met-enkephalin-like peptides from dog adrenal medulla, In E. Costa and M. Trabucchi (Eds.), Regulatory Peptides: From Molecular Biology to Function. Raven Press, New York, NY, 1982, pp. 209-215.
21. Holgert, H., Åman, K., Cozzari, C., Hartman, B.K., Brimijoin, S., Emson, P., Goldstein, M. and Hökfelt, T., The cholinergic innervation of the adrenal gland and its relation to enkephalin and nitric oxide synthase, Neuroreport, 6 (1995) 2576-2580.
22. Hunter, L.W., Rorie, D.K. and Tyce, G.M., Dihydroxyphenylalanine and dopamine are released from portal vein together with noradrenaline and dihydroxyphenylglycol during nerve stimulation, J. Neurochem., 59 (1992) 972-982.
23. Kajihara, H., Akimoto, T. and Iijima, S., On the chromaffin cell in adrenal medulla: with special reference to the small granule cells (SGC cells), Cell Tissue Res., 191 (1978) 1-14.
24. Kopin, I.J., Catecholamine metabolism: Basic aspects and clinical significance, Pharmacol. Rev., 37 (1985) 333-364.
25. Lucas, D. and Yaksh, T.L., Release in vivo of met-enkephalin and encrypted forms of met-enkephalin from brain and spinal cord of the anesthetized cat, Peptides, 11 (1990) 1119-1125.
26. Ma, S. and Long, J.P., Effects of nitroglycerin on release, synthesis and metabolism of norepinephrine and activation of tyrosine hydroxylase in guinea-pigs, Eur. J. Pharmacol., 199 (1991) 27-33.
27. Maas, J.W., Benensohn, H. and Landis, D.H., A kinetic study of the disposition of circulating norepinephrine in normal male subjects, J. Pharmacol. Exp. Ther., 174 (1970) 381-387.
28. Marley, P.D., McLeod, J., Anderson, C. and Thomson, K.A., Nerves containing nitric oxide synthase and their possible function in the control of catecholamine secretion in the bovine adrenal medulla, J. Auton. Nerv. Syst., 54 (1995) 184-194.
29. McKinzie, S., Tyce, G.M. and Brimijoin, S., Lowered norepinephrine turnover as a sign of impaired ganglionic transmission after preganglionic lesioning by acetylcholinesterase antibodies, J. Pharmacol. Exp. Ther., 27 (1996) 817-822.
30. Moncada, S., Palmer, R.M.J. and Higgs, E.A., Nitric oxide: physiology, pathophysiology and pharmacology, Pharmacol. Rev., 43 (1991) 109-142.
31. Oset-Gasque, M.J., Parramón, M., Hortelano, S., Boscá, L. and González, M.P., Nitric oxide implication in the control of neurosecretion by chromaffin cells, J. Neurochem., 63 (1994) 1693-1700.
32. Peterson, D.A., Peterson D.C., Archer, S. and Weir, E.K., The non specificity of specific nitric oxide synthase inhibitors, Biochem. Biophys. Res. Commun., 187 (1992) 797-801.
33. Robinson, R.L., Stimulation of the release of catecholamines from isolated adrenal glands by tyramine, J. Pharmacol. Exp. Ther., 151 (1966) 55-58.
34. Rorie, D.K., Hunter, L.W. and Tyce, G.M., Dihydroxyphenylglycol as an index of neuronal uptake in dog saphenous vein, Am. J. Physiol., 257 (1989) H1945-H1951.
35. Rorie, D.K., Muldoon, S.M. and Tyce, G.M., Disposition of norepinephrine during nerve stimulation of dog saphenous vein, Am. J. Physiol., 239 (1980) H238-H246.
36. Schneider, A.S., Muscarinic receptor mechanisms in adrenal chromaffin cells, In K. Rosenheck and P.I. Lelkes (Eds.), Stimulus-Secretion Coupling in Chromaffin Cells, Vol. II. CRC Press, Inc., Boca Raton, FL, 1987, pp. 51-70.
37. Schneider, A.S., Cline, H.T. and Lemaire, S., Rapid rise in cyclic GMP accompanies catecholamine secretion in suspensions of isolated adrenal chromaffin cells, Life Sci., 24 (1979) 1389-1394.
38. Snyder, S.H. and Bredt, D.S., Nitric oxide as a neuronal messenger, Trends Pharmacol. Sci., 12 (1991) 125-128.
39. Thatikunta, P., Chakder, S. and Rattan, S., Nitric oxide synthase inhibitor inhibits catecholamines release caused by hypogastric sympathetic nerve stimulation, J. Pharmacol. Exp. Ther., 267 (1993) 1363-1368.
40. Wakade, T.D., Poosch, M.S., Bannon, M.J. and Wakade, A.R., Noradrenaline transporter function and transporter mRNA levels in rat adrenal chromaffin cells, 8th International Symposium on Chromaffin Cell Biology, Edinburgh, Scotland (1995) p. 81 (abstract).
41. ω-Nitro-L-arginine, an inhibitor of nitric oxide synthesis, decreases noradrenaline outflow in rat isolated perfused mesenteric vasculature, Naunyn-Schmiedeberg's Arch. Pharmacol., 347 (1993) 238-240.
42. Yang, H.-Y.T., Hexum, T. and Costa, E., Opioid peptides in adrenal gland, Life Sci., 27 (1980) 1119-1125.